6M
BIO icon

6 Meridian’s Bio-Rad Laboratories Class A BIO Stock Holding History

6 Meridian’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-337
Closed -$217K – 404
2021
Q2 		$217K Buy
+337
New +$205K 0.02% 333
2021
Q1 		– Sell
-351
Closed -$205K – 405
2020
Q4 		$205K Buy
+351
New +$200K 0.02% 282
2018
Q1 		– Sell
-1,998
Closed -$477K – 418
2017
Q4 		$477K Buy
+1,998
New +$484K 0.06% 256

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

6 Meridian's BIO Position: Q3 2021 in Review

6 Meridian sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2021, closing a stake of 337 shares — an estimated $217K sold.

6 Meridian first reported a position in BIO in Q4 2017 and held it in 3 quarters. The position peaked at $477K in Q4 2017. 508 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

  • 6 Meridian reported no remaining Bio-Rad Laboratories Class A position as of Q3 2021 after selling out during the quarter.
  • 6 Meridian sold 337 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $217K.
  • 6 Meridian first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and held it in 3 quarters.
  • 6 Meridian's Bio-Rad Laboratories Class A position peaked at $477K in Q4 2017.
  • 508 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.